01 1Aurobindo Pharma Limited
02 1Biocon Limited
03 1Chromo Laboratories India Private Limited
04 1Jubilant Pharmova Limited
05 2USV Private Limited
01 1REPAGLINIDE
02 4Repaglinide
03 1repaglinide
01 6India
NDC Package Code : 65862-532
Start Marketing Date : 2024-01-10
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65727-010
Start Marketing Date : 2004-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 52562-500
Start Marketing Date : 2012-08-08
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65372-1155
Start Marketing Date : 2011-03-22
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 62147-0013
Start Marketing Date : 2009-12-17
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 62147-0055
Start Marketing Date : 2009-12-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
12
PharmaCompass offers a list of Repaglinide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Repaglinide manufacturer or Repaglinide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Repaglinide manufacturer or Repaglinide supplier.
PharmaCompass also assists you with knowing the Repaglinide API Price utilized in the formulation of products. Repaglinide API Price is not always fixed or binding as the Repaglinide Price is obtained through a variety of data sources. The Repaglinide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A CAS-135062-02-1 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of CAS-135062-02-1, including repackagers and relabelers. The FDA regulates CAS-135062-02-1 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. CAS-135062-02-1 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of CAS-135062-02-1 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A CAS-135062-02-1 supplier is an individual or a company that provides CAS-135062-02-1 active pharmaceutical ingredient (API) or CAS-135062-02-1 finished formulations upon request. The CAS-135062-02-1 suppliers may include CAS-135062-02-1 API manufacturers, exporters, distributors and traders.
click here to find a list of CAS-135062-02-1 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing CAS-135062-02-1 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for CAS-135062-02-1 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture CAS-135062-02-1 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain CAS-135062-02-1 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a CAS-135062-02-1 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of CAS-135062-02-1 suppliers with NDC on PharmaCompass.
We have 5 companies offering CAS-135062-02-1
Get in contact with the supplier of your choice:
